Citigroup »

Vor Biopharma shares owned by Citigroup

Quarter-by-quarter ownership of Vor Biopharma (VOR) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Vor Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Vor Biopharma held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vor Biopharma by Citigroup

Quarter filed Position value Share count Share price at filing
2026-03-31 $96k 5.4k 17.84

More positions owned by Citigroup

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Bank of America Corporation (BAC)

View all positions for Citigroup

Top funds holding Vor Biopharma

TCG Crossover Management
RA Capital Management
Fcpm Iii Services B.v.
VR Adviser
Frazier Life Sciences Management
FMR
Dr. Jeffrey R. Jay, M.D.
Paradigm Biocapital Advisors
Vanguard Capital Management
Susquehanna International
Caligan Partners
BlackRock
Vanguard Group
Logos Global Management
Boothbay Fund Management

View all funds holding Vor Biopharma